Ophthalmic Sutures Market Size By Type (Natural, Synthetic), By Absorption (Absorbable, Non-absorbable), By Application (Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy, Iridectomy, Oculoplastic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers [ASCs]), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Industry trends

Ophthalmic Sutures Market size was valued at more than USD 297 million in 2020 and is expected to witness over 7.2% CAGR from 2021 to 2027. An ophthalmic suture is a filament of material widely used to ligate blood vessels and to hold tissues together. Growing awareness regarding different eye disorders and surging funding for several eye-based research through government bodies and private as well as public companies stimulates the market demand. Similarly, surging emphasis of various industry players on developing innovative and efficient ophthalmic sutures will prove beneficial for the overall market growth.
 

Get more details on this report - Request Free Sample PDF
 

Moreover, the COVID-19 pandemic had a significant impact on the industry. Following the guidelines published by the Government of India (GoI) related to COVID-19, surgical procedures that can be safely postponed without additional notable risk to the patient, were delayed after the pandemic. Thus, in 2020, the impact of COVID-19 on ophthalmic sutures in first and second quarter was extensive. This resulted in a substantial drop in ophthalmic suture business revenue generation in 2020 as compared to the historic figures. However, on the good side, government of different countries have given clearance for functioning of eye care facilities for better patient engagement and care.  Thus, it will open several lucrative growth opportunities for the market in the coming years.
 

Increased prevalence of vision impairment throughout the world will escalate the necessity and market value for ophthalmic sutures

Rising incidence of eye ailments in developing as well as developed countries will drive the market expansion during the forecast timeframe. Demographic shift has led to an increased prevalence of several ophthalmic and ocular conditions including age-related macular degeneration, diabetic retinopathy, glaucoma, cataract and blindness or low vision. Globally, the leading causes of vision impairment and blindness are cataracts and uncorrected refractive errors.
 

Growing usage of synthetic sutures among healthcare professionals will spur the ophthalmic sutures market revenue

The synthetic segment accounted for USD 210 million in 2020. Synthetic sutures are the modern sutures, extensively used in different ophthalmic treatments. These sutures diminish the chance of eye contagion and is accessible in different sizes. Synthetic sutures are strong enough to hold tissue and flexible enough to be knotted proving beneficial for the market progression.
 

Increasing adoption of absorbable ophthalmic sutures in different eye procedures will offer the significant market growth

The absorbable segment is estimated to showcase around 7.5% growth rate till 2027. Absorbable sutures break down safely in the body over a certain period of time without intervention that will increase the industry demand. The type of suture used in different ophthalmic procedures varies depending on the discretion, treatment and professional experience of surgeons. In addition, absorbable sutures are often placed internally and does not require re-opening of the wound thus, enhancing its usage in surgical procedures thereby favouring the industry growth.
 

Rising cataract cases will foster the market necessity for different ophthalmic sutures

Get more details on this report - Request Free Sample PDF
 

The cataract surgery held 35% of the ophthalmic sutures market share in 2020 and is forecasted to observe similar growth trend as cataract is the second leading cause of blindness throughout the globe. Cataract diminishes the alertness of vision and is usually predominant among the geriatric population base that surges the industry progression. Moreover, numerous risk factors responsible for cataract including long-term exposure to UV rays, diabetes, hereditary influences, eye injuries and smoking will favour the overall market expansion.
 

Higher usage of ophthalmic sutures in hospital settings will offer lucrative growth opportunity to the market

The hospitals segment captured 28% of revenue share in 2020 due to increasing prevalence of eye disorders such as glaucoma, cataract, retinitis, and others in most parts of the world. Availability of emergency facilities along with well-established healthcare infrastructure in developed countries along with developing scenario in low-income economies will augment the market revenue.
 

Growing cases of eye disorders in North America region will accelerate the market value

Get more details on this report - Request Free Sample PDF
 

North America ophthalmic sutures market is predicted to attain a CAGR of over 6.5% through 2027. Increasing number of ophthalmic surgeries along with technological advancement in the region will enhance the demand for eye procedures thereby fuelling the market demand. Continuous investments in R&D and rising usage of ophthalmic sutures is poised to boost the industry expansion. Furthermore, the industry will similarly prosper owing to rising awareness and acceptance rate of ophthalmic sutures in regional hospitals and ambulatory surgical centers. 
 

Several growth strategies enforced by foremost market leaders have helped them maintain a strong position in the industry

Some of the prominent companies operational in the market include Alcon, Assut Medical, Aurolab, B. Braun, BVI, DemeTECH, FCI (Carl Zeiss Meditec AG), J&J, Mani, Medtronic, Orion Sutures, Surgical Specialties, Teleflex and Unilene among others. These variant industry leaders are undertaking numerous progressive strategies to capture a higher revenue share in this overall market.
 

Some of the recent industry developments:

• In September 2017, Ethicon (Johnson & Johnson) announced the launch of the ProxiSure in the U.S. market. ProxiSure is an improved laparoscopic suturing device featuring Ethicon endomechanical, curved needle and suture technologies. This strategy enabled the company to expand its product portfolio and increase revenue growth.
• Aurolab offers an extensive range of absorbable and non-absorbable sutures. This enhances the overall product portfolio of the firm.
   

The ophthalmic sutures market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Type, 2016-2027 (USD Million)

• Natural
• Synthetic

Market, By Absorption, 2016-2027 (USD Million)

• Absorbable
• Non-absorbable

Market, By Application, 2016-2027 (USD Million)

• Corneal transplantation surgery
• Cataract surgery
• Vitrectomy
• Iridectomy
• Oculoplastic surgery
• Others

Market, By End-use, 2016-2027 (USD Million)

• Hospitals
• ASCs
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE